 Connection
Matthew Wicklund to Myositis, Inclusion Body
This is a "connection" page, showing publications Matthew Wicklund has written about Myositis, Inclusion Body.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.037 |
|
|
|
-
Buchman S, Bandyopadhyay S, Baccon J, Wicklund M. A surprising case of inclusion body myositis with positive endomysial C5b-9 staining. Muscle Nerve. 2016 06; 53(6):991-2.
Score: 0.528
-
Machado PM, McDermott MP, Blaettler T, Sundgreen C, Amato AA, Ciafaloni E, Freimer M, Gibson SB, Jones SM, Levine TD, Lloyd TE, Mozaffar T, Shaibani AI, Wicklund M, Rosholm A, Carstensen TD, Bonefeld K, J?rgensen AN, Phonekeo K, Heim AJ, Herbelin L, Barohn RJ, Hanna MG, Dimachkie MM. Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2023 10; 22(10):900-911.
Score: 0.221
-
He C, Lee JS, Cool CD, Wicklund MP, Fischer A. Development of Autoimmune Interstitial Lung Disease in a Patient with Inclusion Body Myositis. Am J Med. 2019 12; 132(12):e854-e855.
Score: 0.165
-
Bandyopadhyay S, Wicklund M, Specht CS. Novel presentation of Pompe disease: Inclusion-body myositis-like clinical phenotype. Muscle Nerve. 2015 Sep; 52(3):466-7.
Score: 0.124
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|